Does AVALGLUCOSIDASE ALFA-NGPT Cause Off label use? 76 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 76 reports of Off label use have been filed in association with AVALGLUCOSIDASE ALFA-NGPT. This represents 10.3% of all adverse event reports for AVALGLUCOSIDASE ALFA-NGPT.
76
Reports of Off label use with AVALGLUCOSIDASE ALFA-NGPT
10.3%
of all AVALGLUCOSIDASE ALFA-NGPT reports
0
Deaths
2
Hospitalizations
How Dangerous Is Off label use From AVALGLUCOSIDASE ALFA-NGPT?
Of the 76 reports, 2 (2.6%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AVALGLUCOSIDASE ALFA-NGPT. However, 76 reports have been filed with the FAERS database.
What Other Side Effects Does AVALGLUCOSIDASE ALFA-NGPT Cause?
Drug specific antibody present (124)
Weight increased (41)
Weight decreased (34)
Inappropriate schedule of product administration (30)
Fatigue (28)
Dyspnoea (25)
Pyrexia (25)
Illness (23)
Headache (22)
Condition aggravated (21)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which AVALGLUCOSIDASE ALFA-NGPT Alternatives Have Lower Off label use Risk?
AVALGLUCOSIDASE ALFA-NGPT vs AVANAFIL
AVALGLUCOSIDASE ALFA-NGPT vs AVANDAMET
AVALGLUCOSIDASE ALFA-NGPT vs AVANDIA
AVALGLUCOSIDASE ALFA-NGPT vs AVAPRITINIB
AVALGLUCOSIDASE ALFA-NGPT vs AVASTIN